We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

P. Gavin Eastgate Reed Smith LLP

Results 1 to 5 of 6



Damages calculation key to Supreme Court reversal of class certification in Comcast v. Behrend *

USA - March 27 2013
Class certification under Federal Rule of Civil Procedure 23(b)(3) requires a finding that damages attributable to the theory of liability are…

Co-authors: William J. Sheridan, Debra H. Dermody, Daniel I. Booker, Michelle A. Mantine, Jeremy D. Feinstein.


Federal Trade Commission announces adjusted HSR thresholds for 2013 *

USA - January 14 2013
On January 10, 2013, the Federal Trade Commission announced the annual threshold adjustments for premerger filings under the Hart-Scott-Rodino…

Co-authors: William J. Sheridan, Debra H. Dermody, Michelle A. Mantine.


FTC's proposed rule changes modify HSR reporting requirements for pharmaceutical exclusive licensing deals *

USA - August 15 2012
The Federal Trade Commission (“FTC”) is seeking public comment on proposed changes to the premerger notification rules to clarify when the transfer of exclusive marketing, sales and manufacturing rights to a patented pharmaceutical product requires notification to the agencies under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (15 U.S.C. § 18a) (“HSR Act”).

Co-authors: Michelle A. Mantine.


Antitrust agencies announce final changes to HSR filing form *

USA - July 13 2011
On July 7, 2011, the Federal Trade Commission and Department of Justice announced final changes to the Hart-Scott-Rodino (HSR) reporting form.

Co-authors: Debra H. Dermody, Michelle A. Mantine.


Proposed Statement of Antitrust Enforcement Policy regarding Accountable Care Organizations *

USA - April 12 2011
On March 31, 2011, the Federal Trade Commission (FTC) and Department of Justice (DOJ) issued a joint proposed Statement of Enforcement Policy to explain how the agencies intend to enforce U.S. antitrust laws with respect to Accountable Care Organizations (ACOs) - groups of health care providers that will be collaborating under the Patient Protection and Affordable Care Act.

Co-authors: Debra H. Dermody, Michelle A. Mantine.


Next »